These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Prognosis
4599 results:

  • 1.
    Wang JN; Ye B; Cheng F; Yang L; Hu Y; Zheng G; Cai Z; Yu J; Wu W
    Hematology; 2024 Dec; 29(1):2423324. PubMed ID: 39499083
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Lymphocyte subsets in pediatric acute lymphoblastic leukemia and their prognostic value.
    Peng L; Dai Q; Wang Y; Yang H; Shi R; Zhang G; Jiang Y; Ye L
    Medicine (Baltimore); 2024 Nov; 103(44):e40342. PubMed ID: 39496014
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of Simultaneous Presence of Multiple PML-RARA Isoforms on Phenotype in Patients with Acute Promyelocytic Leukaemia.
    Goktas E; Zamani AG; Yildirim MS; Demircioglu S; Tekinalp A; Ceneli O
    J Coll Physicians Surg Pak; 2024 Nov; 34(11):1552-1556. PubMed ID: 39491447
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinical Characteristics and Survival Analysis of Single Center Adult Chronic Myeloid leukemia in Chronic Phase].
    Jiao XX; Zhang YY; Pan J; Song LN; Lin CQ; Shi HZ; Zhu B; Wang SL; Pan SY; Ding ZY; Zhao WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1381-1387. PubMed ID: 39479820
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinical Characteristics and prognosis of Children with Hypodiploid B-cell Precursor Acute Lymphoblastic leukemia].
    Chen CX; Weng KZ; Wen H; Zhuang SQ; Wu XG; Zheng YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1356-1364. PubMed ID: 39479816
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Prognostic factors in children with acute T-lymphoblastic leukemia: a single-center clinical study of the CCCG-ALL-2015 protocol].
    Fu WF; Fang YJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Oct; 26(10):1078-1085. PubMed ID: 39467678
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Construction of a five-gene-based prognostic model for relapsed/refractory acute lymphoblastic leukemia.
    Zhou B; Min B; Liu W; Li Y; Zhu F; Huang J; Fang J; Chen Q; Wu D
    Hematology; 2024 Dec; 29(1):2412952. PubMed ID: 39453390
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth.
    Ghantous A; Nusslé SG; Nassar FJ; Spitz N; Novoloaca A; Krali O; Nickels E; Cahais V; Cuenin C; Roy R; Li S; Caron M; Lam D; Fransquet PD; Casement J; Strathdee G; Pearce MS; Hansen HM; Lee HH; Lee YS; de Smith AJ; Sinnett D; Håberg SE; McKay JA; Nordlund J; Magnus P; Dwyer T; Saffery R; Wiemels JL; Munthe-Kaas MC; Herceg Z
    Mol Cancer; 2024 Oct; 23(1):238. PubMed ID: 39443995
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. New ABL1 Kinase Domain Mutations in bcr::ABL1-Positive Acute Lymphoblastic leukemia.
    Li Z; Peng D; Deng J; Xiong L; Yin P; Hu J; Qian C; Yao L; Yin H; Hong M; Wu Q
    Cancer Med; 2024 Oct; 13(20):e70317. PubMed ID: 39440695
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Recent Developments and Evolving Therapeutic Strategies in KMT2A-Rearranged Acute leukemia.
    Yin L; Wan L; Zhang Y; Hua S; Shao X
    Cancer Med; 2024 Oct; 13(20):e70326. PubMed ID: 39428967
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The significance of MRD-based strategy by dynamic assessment to guide treatment decisions in B-ALL - the enlightenment provided by demonstrating survival differences in the retrospective study.
    Chen Y; Liu R; Li J
    Hematology; 2024 Dec; 29(1):2415589. PubMed ID: 39417653
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Ruxolitinib combined with venetoclax and azacitidine in the treatment of refractory T-ALL patients with JAK1, JAK3, and STAT5B gene mutations: a case report and literature review].
    Xu PP; Zhou T; Xu YY; Peng MX; Du Y; Xie T; Yang YG; Ouyang J; Chen B
    Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):872-875. PubMed ID: 39414615
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Clinical analysis of 7 cases of acute B cell lymphoblastic leukemia with t (17;19) (q21-22;p13)/TCF3-HLF fusion].
    Pu Y; Liu Y; Zhou XY; Song BQ; Zhang J; Yan WH; Wang Q; Cen JN; Shen HJ; Wang QR; Chen SN; Pan JL; Qiu HY
    Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):867-871. PubMed ID: 39414614
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Enhancer looping protein LDB1 modulates MYB expression in T-ALL cell lines in vitro by cooperating with master transcription factors.
    Li Y; Zhang Z; Yu J; Yin H; Chu X; Cao H; Tao Y; Zhang Y; Li Z; Wu S; Hu Y; Zhu F; Gao J; Wang X; Zhou B; Jiao W; Wu Y; Yang Y; Chen Y; Zhuo R; Yang Y; Zhang F; Shi L; Hu Y; Pan J; Hu S
    J Exp Clin Cancer Res; 2024 Oct; 43(1):283. PubMed ID: 39385230
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic Relevance of Immunophenotyping in Adult Patients with Acute leukemia in Turkey: A Single-Center Experience.
    Demirelce O; Orhan B; Sonmez D; Topac FH; Turk RI; Altindal S; Inal BB
    Clin Lab; 2024 Oct; 70(10):. PubMed ID: 39382931
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Investigation of Clinical Value of NKT-like Cells in Tumor Diseases.
    Chen Y; Yang X; Gu C; Zhang Z; Yang X
    Clin Lab; 2024 Oct; 70(10):. PubMed ID: 39382907
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Chronic myeloid leukemia: 2024 update on novel therapeutic strategies].
    Minami Y; Yoshimaru R
    Rinsho Ketsueki; 2024; 65(9):976-981. PubMed ID: 39358298
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Management of children and adolescents receiving CAR-T cell therapy for acute lymphoblastic leukemia].
    Imai C
    Rinsho Ketsueki; 2024; 65(9):1164-1173. PubMed ID: 39358274
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. PBA2, a novel inhibitor of the β-catenin/CBP pathway, eradicates chronic myeloid leukemia including bcr-ABL T315I mutation.
    Yang K; Fu K; Zhang H; Wang X; To KKW; Yang C; Wang F; Chen ZS; Fu L
    Mol Cancer; 2024 Sep; 23(1):209. PubMed ID: 39342174
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia.
    Zhao J; Wang G; Yan G; Zheng M; Li H; Bai Y; Zheng X; Chen Z
    BMC Cancer; 2024 Sep; 24(1):1172. PubMed ID: 39304860
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 230.